The most significantly differentially expressed genes in CNS and nodal large B-cell lymphomas
Gene function and accession no. . | Name . | FDR . | RAWP . | CNS/LN ratio . |
---|---|---|---|---|
Genes with higher level of expression in PCNSL | ||||
Cell cycle, proliferation, and growth | ||||
W87741 | v-Myc myelocytomatosis viral oncogene homolog | 0.0056 | < .001 | 2.74 |
AA464689 | Myc-induced nuclear antigen | 0.0062 | < .001 | 1.54 |
AA669443 | Eukaryotic translation initiation factor 5 | 0.0043 | < .001 | 2.02 |
H56918 | Eukaryotic translation initiation factor 4A | 0.0043 | < .001 | 5.58 |
AA086475 | Cullin 5 | 0.0077 | < .001 | 2 |
AA455521 | E2F5 transcription factor 5 | 0.0077 | < .001 | 4.2 |
H38804 | Mitotic checkpoint protein BUB 3 | 0.0089 | .005 | 2.55 |
AA453663 | Pim-1 | 0.035 | .005 | 2.46 |
AA284634 | Janus kinase 1 | 0.056 | .009 | 1.86 |
Unfolded protein response | ||||
W90128 | X-box binding protein 1 | 0.0043 | < .001 | 4.59 |
AA707661 | Activating transcription factor 6 | 0.001 | < .001 | 1.87 |
Programmed cell death | ||||
W01536 | Programmed cell death 4 | 0.0043 | < .001 | 5.41 |
W70189 | Fas (TNFRSF6)-associated factor 1 | 0.0043 | < .001 | 2.22 |
N94588 | Caspase-8 and FADD-like apoptosis regulator | 0.064 | .01 | 2.2 |
Invasion, adhesion, stromal environment | ||||
AA425451 | Integrin alpha E (CD103) | 0.036 | .005 | 1.79 |
N20475 | Cathepsin-D | 0.0056 | < .001 | 2.35 |
Genes with lower level of expression in PCNSL | ||||
Transcription factor | ||||
AA001604 | Zinc finger 36 | 0.0056 | .002 | 0.56 |
AA701046 | Myeloid/lymphoid or mixed lineage leukemia | 0.0043 | .001 | 0.49 |
H84982 | Checkpoint suppressor 1 | 0.015 | < .001 | 0.36 |
Signal transduction | ||||
AA455591 | EphB3 | 0.0043 | .001 | 0.56 |
H67666 | Ribosomal S6 kinase, 90 kDa, polypeptide 3 | 0.0099 | < .001 | 0.43 |
AA148524 | Discoidin domain receptor family member 2 | 0.0043 | < .001 | 0.47 |
Invasion, adhesion, stromal environment | ||||
AA099554 | Disintegrin and metalloprotease domain 12 | 0.009 | < .001 | 0.42 |
AA936799 | Matrix metalloprotease 2 | 0.0056 | < .001 | 0.15 |
AA430540 | Collagen type IV alpha 2 | 0.01 | < .001 | 0.5 |
R75636 | Collagen type V alpha 1 | 0.015 | .001 | 0.54 |
H16637 | Vascular cell adhesion molecule 1 | 0.034 | .005 | 0.49 |
H97778 | E-cadherin | 0.039 | .006 | 0.48 |
N64384 | Integrin alpha X (CD11C) | 0.025 | .003 | 0.32 |
Gene function and accession no. . | Name . | FDR . | RAWP . | CNS/LN ratio . |
---|---|---|---|---|
Genes with higher level of expression in PCNSL | ||||
Cell cycle, proliferation, and growth | ||||
W87741 | v-Myc myelocytomatosis viral oncogene homolog | 0.0056 | < .001 | 2.74 |
AA464689 | Myc-induced nuclear antigen | 0.0062 | < .001 | 1.54 |
AA669443 | Eukaryotic translation initiation factor 5 | 0.0043 | < .001 | 2.02 |
H56918 | Eukaryotic translation initiation factor 4A | 0.0043 | < .001 | 5.58 |
AA086475 | Cullin 5 | 0.0077 | < .001 | 2 |
AA455521 | E2F5 transcription factor 5 | 0.0077 | < .001 | 4.2 |
H38804 | Mitotic checkpoint protein BUB 3 | 0.0089 | .005 | 2.55 |
AA453663 | Pim-1 | 0.035 | .005 | 2.46 |
AA284634 | Janus kinase 1 | 0.056 | .009 | 1.86 |
Unfolded protein response | ||||
W90128 | X-box binding protein 1 | 0.0043 | < .001 | 4.59 |
AA707661 | Activating transcription factor 6 | 0.001 | < .001 | 1.87 |
Programmed cell death | ||||
W01536 | Programmed cell death 4 | 0.0043 | < .001 | 5.41 |
W70189 | Fas (TNFRSF6)-associated factor 1 | 0.0043 | < .001 | 2.22 |
N94588 | Caspase-8 and FADD-like apoptosis regulator | 0.064 | .01 | 2.2 |
Invasion, adhesion, stromal environment | ||||
AA425451 | Integrin alpha E (CD103) | 0.036 | .005 | 1.79 |
N20475 | Cathepsin-D | 0.0056 | < .001 | 2.35 |
Genes with lower level of expression in PCNSL | ||||
Transcription factor | ||||
AA001604 | Zinc finger 36 | 0.0056 | .002 | 0.56 |
AA701046 | Myeloid/lymphoid or mixed lineage leukemia | 0.0043 | .001 | 0.49 |
H84982 | Checkpoint suppressor 1 | 0.015 | < .001 | 0.36 |
Signal transduction | ||||
AA455591 | EphB3 | 0.0043 | .001 | 0.56 |
H67666 | Ribosomal S6 kinase, 90 kDa, polypeptide 3 | 0.0099 | < .001 | 0.43 |
AA148524 | Discoidin domain receptor family member 2 | 0.0043 | < .001 | 0.47 |
Invasion, adhesion, stromal environment | ||||
AA099554 | Disintegrin and metalloprotease domain 12 | 0.009 | < .001 | 0.42 |
AA936799 | Matrix metalloprotease 2 | 0.0056 | < .001 | 0.15 |
AA430540 | Collagen type IV alpha 2 | 0.01 | < .001 | 0.5 |
R75636 | Collagen type V alpha 1 | 0.015 | .001 | 0.54 |
H16637 | Vascular cell adhesion molecule 1 | 0.034 | .005 | 0.49 |
H97778 | E-cadherin | 0.039 | .006 | 0.48 |
N64384 | Integrin alpha X (CD11C) | 0.025 | .003 | 0.32 |
False discovery rate (FDR) corresponds to the expected proportion of falsely called genes among the genes declared to be differentially expressed. RAWP corresponds to the permutation-based unadjusted P value.